As shown in Figure 5A and B, our results disclosed that higher expression of PTGS2/ESR2/EGFR/JUN/MMP2 genes’ signature associated with the most aggressive breast cancer subtypes donating by basal breast cancer (P < .00001) and the ER-negative breast tumors ( P < .00001). The gene discussed is EGFR; the disease is breast carcinoma.